CandlesenseCandlesense
AMRX•benzinga•

Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson's Drug But Q1 Earnings Are Mixed

Summary

Amneal Pharmaceuticals reported first-quarter 2025 adjusted earnings per share of 21 cents, up from 14 cents a year ago.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 2, 2025 by benzinga

← Back to AMRX News
    Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson's Drug But Q1 Earnings Are Mixed | AMRX Stock News | Candlesense